Scientists say that blocking a protein called DLK could help protect against neurodegeneration of demyelinated nerve cells in ...

People with multiple sclerosis (MS) often stop taking disease-modifying ... patients tend to experience fewer relapses and less disease activity but show more evidence of neuronal degeneration.

Reference: “Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of ...

Now, researchers from University of California San Diego and their colleagues report that they have identified a key pathway ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

The following is a summary of “Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap,” published in the November 2024 issue of ...

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral ...

Targeting ceramide synthase enzymes may reduce multiple sclerosis severity by limiting ceramide C16 synthesis, offering ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative co ...

Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...